The DOI matches its Crossref record; 348 of the 348 references it cites were found in a registry or an index.
Biomarkers in Cancer Detection, Diagnosis, and Prognosis
Open accessAbstract
Biomarkers are vital in healthcare as they provide valuable insights into disease diagnosis, prognosis, treatment response, and personalized medicine. They serve as objective indicators, enabling early detection and intervention, leading to improved patient outcomes and reduced costs. Biomarkers also guide treatment decisions by predicting disease outcomes and facilitating individualized treatment plans. They play a role in monitoring disease progression, adjusting treatments, and detecting early signs of recurrence. Furthermore, biomarkers enhance drug development and clinical trials by identifying suitable patients and accelerating the approval process. In this review paper, we described a variety of biomarkers applicable for cancer detection and diagnosis, such as imaging-based diagnosis (CT, SPECT, MRI, and PET), blood-based biomarkers (proteins, genes, mRNA, and peptides), cell imaging-based diagnosis (needle biopsy and CTC), tissue imaging-based diagnosis (IHC), and genetic-based biomarkers (RNAseq, scRNAseq, and spatial transcriptomics).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Therasse, P., Arbuck, S. G., Eisenhauer, E. A., Wanders, J., Kaplan, R. S., Rubinstein, L., Verweij, J., Van Glabbeke, M., van Oosterom, A. T., Christian, M. C., et al. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.205 · Cited by 15,660
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
MicroRNA expression profiles classify human cancers
Lu, J., Getz, G., Miska, E. A., Alvarez-Saavedra, E., Lamb, J., Peck, D., Sweet-Cordero, A., Ebert, B. L., Mak, R. H., Ferrando, A. A., et al. (2005) · Nature · doi:10.1038/nature03702 · Cited by 9,539
Edge, S. B., & Compton, C. C. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-010-0985-4 · Cited by 9,029
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Circular RNAs are a large class of animal RNAs with regulatory potency
Memczak, S., Jens, M., Elefsinioti, A., Torti, F., Krueger, J., Rybak, A., Maier, L., Mackowiak, S. D., Gregersen, L. H., Munschauer, M., et al. (2013) · Nature · doi:10.1038/nature11928 · Cited by 7,990
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1997 · Cited by 7,590
Bang, Y.-J., Van Cutsem, E., Feyereislova, A., Chung, H. C., Shen, L., Sawaki, A., Lordick, F., Ohtsu, A., Omuro, Y., Satoh, T., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61121-x · Cited by 7,302
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
The emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926
Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1371 · Cited by 5,485
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1093 · Cited by 5,151
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
The immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981
The biogenesis, biology and characterization of circular RNAs
Kristensen, L. S., Andersen, M. S., Stagsted, L. V. W., Ebbesen, K. K., Hansen, T. B., & Kjems, J. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0158-7 · Cited by 4,823
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Anderson, N. L., & Anderson, N. G. (2002) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r200007-mcp200 · Cited by 4,414
Serial Analysis of Gene Expression
Velculescu, V. E., Zhang, L., Vogelstein, B., & Kinzler, K. W. (1995) · Science · doi:10.1126/science.270.5235.484 · Cited by 3,711
Gene Silencing in Cancer in Association with Promoter Hypermethylation
Herman, J. G., & Baylin, S. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023075 · Cited by 3,422
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,409
Principles of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2011) · The Lancet · doi:10.1016/s0140-6736(11)60993-8 · Cited by 3,075
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051
Colorectal cancer statistics, 2014
Siegel, R., DeSantis, C., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21220 · Cited by 2,562
Sanger, H. L., Klotz, G., Riesner, D., Gross, H. J., & Kleinschmidt, A. K. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.11.3852 · Cited by 2,296
The immune contexture in cancer prognosis and treatment
Fridman, W. H., Zitvogel, L., Sautès–Fridman, C., & Kroemer, G. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.101 · Cited by 2,263
KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer
Lièvre, A., Bachet, J.-B., Le Corre, D., Boige, V., Landi, B., Emile, J.-F., Côté, J.-F., Tomasic, G., Penna, C., Ducreux, M., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0191 · Cited by 2,229
Neuroblastoma: biological insights into a clinical enigma
Brodeur, G. M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1014 · Cited by 2,160
Campo, E., Swerdlow, S. H., Harris, N. L., Pileri, S., Stein, H., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2011-01-293050 · Cited by 2,008
Willett, C. G., Boucher, Y., di Tomaso, E., Duda, D. G., Munn, L. L., Tong, R. T., Chung, D. C., Sahani, D. V., Kalva, S. P., Kozin, S. V., et al. (2004) · Nature Medicine · doi:10.1038/nm988 · Cited by 1,966
Integrating liquid biopsies into the management of cancer
Siravegna, G., Marsoni, S., Siena, S., & Bardelli, A. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.14 · Cited by 1,908
Multitarget Stool DNA Testing for Colorectal-Cancer Screening
Imperiale, T. F., Ransohoff, D. F., Itzkowitz, S. H., Levin, T. R., Lavin, P., Lidgard, G. P., Ahlquist, D. A., & Berger, B. M. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1311194 · Cited by 1,900
PI3K pathway alterations in cancer: variations on a theme
Yuan, T. L., & Cantley, L. C. (2008) · Oncogene · doi:10.1038/onc.2008.245 · Cited by 1,845
(1977) · PubMed · Cited by 1,801
Biogenesis and secretion of exosomes
Kowal, J., Tkach, M., & Théry, C. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.05.004 · Cited by 1,781
Robert, C., Ribas, A., Wolchok, J. D., Hodi, F. S., Hamid, O., Kefford, R., Weber, J. S., Joshua, A. M., Hwu, W.-J., Gangadhar, T. C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60958-2 · Cited by 1,774
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Marisa, L., de Reyniès, A., Duval, A., Selves, J., Gaub, M. P., Vescovo, L., Etienne-Grimaldi, M.-C., Schiappa, R., Guenot, D., Ayadi, M., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001453 · Cited by 1,507
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis
Zhou, W., Fong, M. Y., Min, Y., Somlo, G., Liu, L., Palomares, M. R., Yu, Y., Chow, A., O’Connor, S. T. F., Chin, A. R., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.03.007 · Cited by 1,476
Liyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours
Galon, J., Mlecnik, B., Bindea, G., Angell, H. K., Berger, A., Lagorce, C., Lugli, A., Zlobec, I., Hartmann, A., Bifulco, C., et al. (2014) · The Journal of Pathology · doi:10.1002/path.4287 · Cited by 1,360
Ha, D., Yang, N., & Nadithe, V. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.02.001 · Cited by 1,346
Hammarström, S. (1999) · Seminars in Cancer Biology · doi:10.1006/scbi.1998.0119 · Cited by 1,300
Cancer risk in mutation carriers of DNA-mismatch-repair genes
Aarnio, M., Sankila, R., Pukkala, E., Salovaara, R., Aaltonen, L. A., de la Chapelle, A., Peltom�ki, P., Mecklin, J.-P., & J�rvinen, H. J. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990412)81:2<214::aid-ijc8>3.0.co;2-l · Cited by 1,278
Vaddepally, R. K., Kharel, P., Pandey, R., Garje, R., & Chandra, A. B. (2020) · Cancers · doi:10.3390/cancers12030738 · Cited by 1,196
Histone acetylation and an epigenetic code
Turner, B. M. (2000) · BioEssays · doi:10.1002/1521-1878(200009)22:9<836::aid-bies9>3.0.co;2-x · Cited by 1,182
Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
Zhang, L., Zhang, S., Yao, J., Lowery, F. J., Zhang, Q., Huang, W.-C., Li, P., Li, M., Wang, X., Zhang, C., et al. (2015) · Nature · doi:10.1038/nature15376 · Cited by 1,175
Allegra, C. J., Jessup, J. M., Somerfield, M. R., Hamilton, S. R., Hammond, E. H., Hayes, D. F., McAllister, P. K., Morton, R. F., & Schilsky, R. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9170 · Cited by 1,156
The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration
Bossuyt, P. M., Reitsma, J. B., Bruns, D. E., Gatsonis, C. A., Glasziou, P. P., Irwig, L. M., Moher, D., Rennie, D., de Vet, H. C. W., & Lijmer, J. G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-1-200301070-00012-w1 · Cited by 1,124
Imaging biomarker roadmap for cancer studies
O'Connor, J. P. B., Aboagye, E. O., Adams, J. E., Aerts, H. J. W. L., Barrington, S. F., Beer, A. J., Boellaard, R., Bohndiek, S. E., Brady, M., Brown, G., et al. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.162 · Cited by 1,091
Plana, J. C., Galderisi, M., Barac, A., Ewer, M. S., Ky, B., Scherrer-Crosbie, M., Ganame, J., Sebag, I. A., Agler, D. A., Badano, L. P., et al. (2014) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeu192 · Cited by 1,058
Mlecnik, B., Bindea, G., Angell, H. K., Maby, P., Angelova, M., Tougeron, D., Church, S. E., Lafontaine, L., Fischer, M., Fredriksen, T., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.025 · Cited by 1,034
Hewitson, P., Glasziou, P., Watson, E., Towler, B., & Irwig, L. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01875.x · Cited by 990
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Kasinski, A. L., & Slack, F. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3166 · Cited by 936
Quantification of Plasma Epstein–Barr Virus DNA in Patients with Advanced Nasopharyngeal Carcinoma
Lin, J.-C., Wang, W.-Y., Chen, K. Y., Wei, Y.-H., Liang, W.-M., Jan, J.-S., & Jiang, R.-S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032260 · Cited by 909
Stem Cells and Cancer: Two Faces of Eve
Clarke, M. F., & Fuller, M. (2006) · Cell · doi:10.1016/j.cell.2006.03.011 · Cited by 905
Farazi, T. A., Spitzer, J. I., Morozov, P., & Tuschl, T. (2011) · The Journal of Pathology · doi:10.1002/path.2806 · Cited by 895
Clinical relevance of host immunity in breast cancer: from TILs to the clinic
Savas, P., Salgado, R., Denkert, C., Sotiriou, C., Darcy, P. K., Smyth, M. J., & Loi, S. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.215 · Cited by 890
Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation
Webber, J., Steadman, R., Mason, M. D., Tabi, Z., & Clayton, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1722 · Cited by 852
Lieu, E. L., Nguyen, T., Rhyne, S., & Kim, J. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0375-3 · Cited by 818
Circulating tumour cells in cancer patients: challenges and perspectives
Pantel, K., & Alix-Panabières, C. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.07.001 · Cited by 815
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Köbel, M., Kalloger, S. E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N. J., Ionescu, D. N., Rajput, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050232 · Cited by 814
Thompson, M. P., & Kurzrock, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0670-3 · Cited by 786
Tumor-Derived Exosomes and Their Role in Cancer Progression
(2016) · Advances in Clinical Chemistry · doi:10.1016/bs.acc.2015.12.005 · Cited by 755
Woo, E. Y., Yeh, H., Chu, C. S., Schlienger, K., Carroll, R. G., Riley, J. L., Kaiser, L. R., & June, C. H. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4272 · Cited by 696
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Haber, D. A., & Velculescu, V. E. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-1014 · Cited by 694
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Huang, X., Yuan, T., Liang, M., Du, M., Xia, S., Dittmar, R., Wang, D., See, W., Costello, B. A., Quevedo, F., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.07.035 · Cited by 681
Emerging molecular markers of cancer
Sidransky, D. (2002) · Nature Reviews Cancer · doi:10.1038/nrc755 · Cited by 662
Clinical implications of PTEN loss in prostate cancer
Jamaspishvili, T., Berman, D. M., Ross, A. E., Scher, H. I., De Marzo, A. M., Squire, J. A., & Lotan, T. L. (2018) · Nature Reviews Urology · doi:10.1038/nrurol.2018.9 · Cited by 651
Ilic, D., Djulbegovic, M., Jung, J. H., Hwang, E. C., Zhou, Q., Cleves, A., Agoritsas, T., & Dahm, P. (2018) · BMJ · doi:10.1136/bmj.k3519 · Cited by 641
Lysophosphatidic Acid as a Potential Biomarker for Ovarian and Other Gynecologic Cancers
Xu, Y. (1998) · JAMA · doi:10.1001/jama.280.8.719 · Cited by 637
Baggerly, K. A., Morris, J. S., & Coombes, K. R. (2004) · Bioinformatics · doi:10.1093/bioinformatics/btg484 · Cited by 621
Computer-Aided Detection and Diagnosis of Breast Cancer With Mammography: Recent Advances
Tang, J., Rangayyan, R. M., Xu, J., El Naqa, I., & Yang, Y. (2009) · IEEE Transactions on Information Technology in Biomedicine · doi:10.1109/titb.2008.2009441 · Cited by 619
Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
Harrison, P. T., Vyse, S., & Huang, P. H. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.015 · Cited by 615
The nuclear lamins: flexibility in function
Burke, B., & Stewart, C. L. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3488 · Cited by 557
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay
Wallden, B., Storhoff, J., Nielsen, T., Dowidar, N., Schaper, C., Ferree, S., Liu, S., Leung, S., Geiss, G., Snider, J., et al. (2015) · BMC Medical Genomics · doi:10.1186/s12920-015-0129-6 · Cited by 542
Gene-promoter hypermethylation as a biomarker in lung cancer
Belinsky, S. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1432 · Cited by 533
Li, L., Li, C., Wang, S., Wang, Z., Jiang, J., Wang, W., Li, X., Chen, J., Liu, K., Li, C., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1625 · Cited by 532
MicroRNAs: Novel Biomarkers for Human Cancer
Bartels, C. L., & Tsongalis, G. J. (2009) · Clinical Chemistry · doi:10.1373/clinchem.2008.112805 · Cited by 529
Gleason grading and prognostic factors in carcinoma of the prostate
Humphrey, P. A. (2004) · Modern Pathology · doi:10.1038/modpathol.3800054 · Cited by 524
Shimi, T., Pfleghaar, K., Kojima, S.-I., Pack, C.-G., Solovei, I., Goldman, A. E., Adam, S. A., Shumaker, D. K., Kinjo, M., Cremer, T., et al. (2008) · Genes & Development · doi:10.1101/gad.1735208 · Cited by 519
Functional role of cardiolipin in mitochondrial bioenergetics
Paradies, G., Paradies, V., De Benedictis, V., Ruggiero, F. M., & Petrosillo, G. (2014) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2013.10.006 · Cited by 511
MRI contrast agents: Classification and application (Review)
Xiao, Y.-D., Paudel, R., Liu, J., Ma, C., Zhang, Z.-S., & Zhou, S.-K. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2744 · Cited by 509
HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
Gajria, D., & Chandarlapaty, S. (2011) · Expert Review of Anticancer Therapy · doi:10.1586/era.10.226 · Cited by 494
Liquid Biopsies, What We Do Not Know (Yet)
Bardelli, A., & Pantel, K. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.01.002 · Cited by 482
Membranes: A meeting point for lipids, proteins and therapies
Escribá, P. V., González‐Ros, J. M., Goñi, F. M., Kinnunen, P. K. J., Vigh, L., Sánchez‐Magraner, L., Fernández, A. M., Busquets, X., Horváth, I., & Barceló‐Coblijn, G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00281.x · Cited by 454
Hyperpolarized 13C MRI: Path to Clinical Translation in Oncology
Kurhanewicz, J., Vigneron, D. B., Ardenkjaer-Larsen, J. H., Bankson, J. A., Brindle, K., Cunningham, C. H., Gallagher, F. A., Keshari, K. R., Kjaer, A., Laustsen, C., et al. (2019) · Neoplasia · doi:10.1016/j.neo.2018.09.006 · Cited by 440
Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes
Webber, J. P., Spary, L. K., Sanders, A. J., Chowdhury, R., Jiang, W. G., Steadman, R., Wymant, J., Jones, A. T., Kynaston, H., Mason, M. D., et al. (2015) · Oncogene · doi:10.1038/onc.2013.560 · Cited by 438
Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma
Sohn, W., Kim, J., Kang, S. H., Yang, S. R., Cho, J.-Y., Cho, H. C., Shim, S. G., & Paik, Y.-H. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2015.68 · Cited by 426
Altomare, D. A., Wang, H. Q., Skele, K. L., Rienzo, A. D., Klein-Szanto, A. J., Godwin, A. K., & Testa, J. R. (2004) · Oncogene · doi:10.1038/sj.onc.1207721 · Cited by 412
Cheng, L., Lopez-Beltran, A., Massari, F., MacLennan, G. T., & Montironi, R. (2018) · Modern Pathology · doi:10.1038/modpathol.2017.104 · Cited by 407
Xia, L., Liu, Y., & Wang, Y. (2019) · The Oncologist · doi:10.1634/theoncologist.2019-io-s1-s05 · Cited by 394
Sahin, I. H., Akce, M., Alese, O., Shaib, W., Lesinski, G. B., El-Rayes, B., & Wu, C. (2019) · British Journal of Cancer · doi:10.1038/s41416-019-0599-y · Cited by 393
Camidge, D. R., Kim, H. R., Ahn, M.-J., Yang, J. C. H., Han, J.-Y., Hochmair, M. J., Lee, K. H., Delmonte, A., Garcia Campelo, M. R., Kim, D.-W., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.07.035 · Cited by 388
Randomized Clinical Trials With Biomarkers: Design Issues
Freidlin, B., McShane, L. M., & Korn, E. L. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp477 · Cited by 369
Exosome biogenesis, bioactivities and functions as new delivery systems of natural compounds
Farooqi, A. A., Desai, N. N., Qureshi, M. Z., Librelotto, D. R. N., Gasparri, M. L., Bishayee, A., Nabavi, S. M., Curti, V., & Daglia, M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.010 · Cited by 359
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
O'Connor, J. P. B., Jackson, A., Parker, G. J. M., Roberts, C., & Jayson, G. C. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2012.2 · Cited by 348
Cyclooxygenases, prostanoids, and tumor progression
Wang, M.-T., Honn, K. V., & Nie, D. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9096-5 · Cited by 345
A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool
Manterola, L., Guruceaga, E., Pérez-Larraya, J. G., González-Huarriz, M., Jauregui, P., Tejada, S., Diez-Valle, R., Segura, V., Samprón, N., Barrena, C., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/not218 · Cited by 345
Salivary Transcriptomic Biomarkers for Detection of Resectable Pancreatic Cancer
Zhang, L., Farrell, J. J., Zhou, H., Elashoff, D., Akin, D., Park, N., Chia, D., & Wong, D. T. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.010 · Cited by 343
Lysophospholipids Are Potential Biomarkers of Ovarian Cancer
Sutphen, R., Xu, Y., Wilbanks, G. D., Fiorica, J., Grendys, E. C., LaPolla, J. P., Arango, H., Hoffman, M. S., Martino, M., Wakeley, K., et al. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.1185.13.7 · Cited by 338
Aga, M., Bentz, G. L., Raffa, S., Torrisi, M. R., Kondo, S., Wakisaka, N., Yoshizaki, T., Pagano, J. S., & Shackelford, J. (2014) · Oncogene · doi:10.1038/onc.2014.66 · Cited by 337
Xu, X., El‐Naggar, A. K., & Lotan, R. (1995) · Europe PMC (PubMed Central) · Cited by 332
Glycerolipid Metabolism and Signaling in Health and Disease
Prentki, M., & Madiraju, S. R. M. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0007 · Cited by 326
MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer
Zhang, Y., Guo, L., Li, Y., Feng, G.-H., Teng, F., Li, W., & Zhou, Q. (2018) · Molecular Cancer · doi:10.1186/s12943-017-0753-1 · Cited by 326
Breast Cancer Lung Metastasis Requires Expression of Chemokine Receptor CCR4 and Regulatory T Cells
Olkhanud, P. B., Baatar, D., Bodogai, M., Hakim, F., Gress, R., Anderson, R. L., Deng, J., Xu, M., Briest, S., & Biragyn, A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4619 · Cited by 312
Exosomal Proteins as Diagnostic Biomarkers in Lung Cancer
Sandfeld-Paulsen, B., Jakobsen, K. R., Bæk, R., Folkersen, B. H., Rasmussen, T. R., Meldgaard, P., Varming, K., Jørgensen, M. M., & Sorensen, B. S. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.034 · Cited by 311
Halama, N., Braun, M., Kahlert, C., Spille, A., Quack, C., Rahbari, N., Koch, M., Weitz, J., Kloor, M., Zoernig, I., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2173 · Cited by 300
ctDNA as a cancer biomarker: A broad overview
Pessoa, L. S., Heringer, M., & Ferrer, V. P. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.103109 · Cited by 298
Current State of Breast Cancer Diagnosis, Treatment, and Theranostics
Bhushan, A., Gonsalves, A., & Menon, J. U. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050723 · Cited by 298
Overexpression and overactivation of Akt in thyroid carcinoma.
Ringel, M. D., Hayre, N., Saito, J., Saunier, B., Schuppert, F., Burch, H., Bernet, V., Burman, K. D., Kohn, L. D., & Saji, M. (2001) · PubMed · Cited by 297
hsa_circ_0013958: a circular RNA and potential novel biomarker for lung adenocarcinoma
Zhu, X., Wang, X., Wei, S., Chen, Y., Chen, Y., Fan, X., Han, S., & Wu, G. (2017) · The FEBS Journal · doi:10.1111/febs.14132 · Cited by 295
Lawrence, H. P. (2002) · PubMed · Cited by 292
Nossov, V., Amneus, M., Su, F., Lang, J., Janco, J. M. T., Reddy, S. T., & Farias-Eisner, R. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.04.009 · Cited by 291
de Caceres, I. I., Battagli, C., Esteller, M., Herman, J. G., Dulaimi, E., Edelson, M. I., Bergman, C., Ehya, H., Eisenberg, B. L., & Cairns, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1529 · Cited by 282
Topography of cancer-associated immune cells in human solid tumors
Kather, J. N., Suarez-Carmona, M., Charoentong, P., Weis, C.-A., Hirsch, D., Bankhead, P., Horning, M., Ferber, D., Kel, I., Herpel, E., et al. (2018) · eLife · doi:10.7554/elife.36967 · Cited by 280
Galectin expression in cancer diagnosis and prognosis: A systematic review
Thijssen, V. L., Heusschen, R., Caers, J., & Griffioen, A. W. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.03.003 · Cited by 279
BRAF targeted therapy changes the treatment paradigm in melanoma
Ribas, A., & Flaherty, K. T. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.69 · Cited by 271
Contribution of oncoproteomics to cancer biomarker discovery
Cho, W. C. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-25 · Cited by 268
Barrett, T., Brechbiel, M., Bernardo, M., & Choyke, P. L. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20991 · Cited by 266
ALK inhibitors in non-small cell lung cancer: crizotinib and beyond.
Awad, M. M., & Shaw, A. T. (2014) · PubMed · Cited by 264
Lin, A., Wei, T., Meng, H., Luo, P., & Zhang, J. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1062-7 · Cited by 264
Epidemiology of hepatitis B virus infection in the Asia–Pacific region
Chen, C., Wang, L., & Yu, M. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02124.x · Cited by 259
Role of Pancreatic Cancer-derived Exosomes in Salivary Biomarker Development
Lau, C., Kim, Y., Chia, D., Spielmann, N., Eibl, G., Elashoff, D., Wei, F., Lin, Y.-L., Moro, A., Grogan, T., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.452458 · Cited by 256
Türeci, Ö., Schmitt, H., Fadle, N., Pfreundschuh, M., & Sahin, U. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6416 · Cited by 255
Vickers, A. J., Savage, C., O'Brien, M. F., & Lilja, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1685 · Cited by 254
A Review of the Role of Carcinoembryonic Antigen in Clinical Practice
Hall, C., Clarke, L., Pal, A., Buchwald, P., Eglinton, T., Wakeman, C., & Frizelle, F. (2019) · Annals of Coloproctology · doi:10.3393/ac.2019.11.13 · Cited by 252
Spindler, K.-L. G., Pallisgaard, N., Vogelius, I., & Jakobsen, A. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0564 · Cited by 251
Zhang, J., Chen, G., Zhang, P., Zhang, J., Li, X., Gan, D., Cao, X., Han, M., Du, H., & Ye, Y. (2020) · PLOS ONE · doi:10.1371/journal.pone.0228857 · Cited by 249
Prognostic and Predictive Roles of KRAS Mutation in Colorectal Cancer
Arrington, A. K., Heinrich, E. L., Lee, W., Duldulao, M., Patel, S., Sanchez, J., Garcia-Aguilar, J., & Kim, J. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131012153 · Cited by 244
Schulze, K., Gasch, C., Staufer, K., Nashan, B., Lohse, A. W., Pantel, K., Riethdorf, S., & Wege, H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28230 · Cited by 244
Roles of Bioactive Sphingolipids in Cancer Biology and Therapeutics
Saddoughi, S. A., Song, P., & Ogretmen, B. (2008) · Subcellular Biochemistry · doi:10.1007/978-1-4020-8831-5_16 · Cited by 243
Sabbatini, P., Larson, S. M., Kremer, A., Zhang, Z.-F., Sun, M., Yeung, H., Imbriaco, M., Horak, I., Conolly, M., Ding, C., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.3.948 · Cited by 237
Mutation of the PTEN tumor suppressor gene in endometrial hyperplasias.
Maxwell, G. L., Risinger, J. I., Gumbs, C. E., Shaw, H., Bentley, R. C., Barrett, J. C., Berchuck, A., & Futreal, P. A. (1998) · PubMed · Cited by 231
Condeelis, J., & Weissleder, R. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003848 · Cited by 230
Identification and characterization of genes associated with human hepatocellular carcinogenesis.
Kondoh, N., Wakatsuki, T., Ryo, A., Hada, A., Aihara, T., Horiuchi, S., Goseki, N., Matsubara, O., Takenaka, K., Shichita, M., et al. (1999) · PubMed · Cited by 229
Lamin A/C Is a Risk Biomarker in Colorectal Cancer
Willis, N. D., Cox, T. R., Rahman-Casañs, S. F., Smits, K., Przyborski, S. A., van den Brandt, P., van Engeland, M., Weijenberg, M., Wilson, R. G., de Bruïne, A., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002988 · Cited by 229
The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer
van Elmpt, W., De Ruysscher, D., van der Salm, A., Lakeman, A., van der Stoep, J., Emans, D., Damen, E., Öllers, M., Sonke, J.-J., & Belderbos, J. (2012) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2012.03.005 · Cited by 229
PTEN Signaling pathways in glioblastoma
Koul, D. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.9.6954 · Cited by 228
Reid, D. M., Doughty, J., Eastell, R., Heys, S. D., Howell, A., McCloskey, E. V., Powles, T., Selby, P., & Coleman, R. E. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.03.007 · Cited by 228
Sphingosine Kinase Type 1 Promotes Estrogen-Dependent Tumorigenesis of Breast Cancer MCF-7 Cells
Nava, V (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5658 · Cited by 226
Terris, B., Blaveri, E., Crnogorac-Jurcevic, T., Jones, M., Missiaglia, E., Ruszniewski, P., Sauvanet, A., & Lemoine, N. R. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61121-2 · Cited by 225
Salivary biomarkers in cancer detection
Wang, X., Kaczor-Urbanowicz, K. E., & Wong, D. T. W. (2017) · Medical Oncology · doi:10.1007/s12032-016-0863-4 · Cited by 225
A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer
Jairath, N. K., Dal Pra, A., Vince, R., Dess, R. T., Jackson, W. C., Tosoian, J. J., McBride, S. M., Zhao, S. G., Berlin, A., Mahal, B. A., et al. (2021) · European Urology · doi:10.1016/j.eururo.2020.11.021 · Cited by 219
Passaro, A., Mok, T., Peters, S., Popat, S., Ahn, M.-J., & de Marinis, F. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2020.12.002 · Cited by 213
Takaishi, S., Okumura, T., & Wang, T. C. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2603 · Cited by 206
CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
Lau, W. M., Teng, E., Chong, H. S., Lopez, K. A. P., Tay, A. Y. L., Salto-Tellez, M., Shabbir, A., So, J. B. Y., & Chan, S. L. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2309 · Cited by 206
Sarkar, S., Maceyka, M., Hait, N. C., Paugh, S. W., Sankala, H., Milstien, S., & Spiegel, S. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.055 · Cited by 205
Mitochondrial phospholipids: role in mitochondrial function
Mejia, E. M., & Hatch, G. M. (2016) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-015-9601-4 · Cited by 204
Tumor-Infiltrating Foxp3−CD4+CD25+ T Cells Predict Poor Survival in Renal Cell Carcinoma
Siddiqui, S. A., Frigola, X., Bonne-Annee, S., Mercader, M., Kuntz, S. M., Krambeck, A. E., Sengupta, S., Dong, H., Cheville, J. C., Lohse, C. M., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2139 · Cited by 202
Human positron emission tomography studies of brain neurokinin 1 receptor occupancy by aprepitant
Bergström, M., Hargreaves, R. J., Burns, H. D., Goldberg, M. R., Sciberras, D., Reines, S. A., Petty, K. J., Ögren, M., Antoni, G., Långström, B., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.007 · Cited by 201
Circulating tumour cells in breast cancer
Ring, A., Smith, I. E., & Dowsett, M. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01381-6 · Cited by 196
Circulating miR-483-3p and miR-21 is highly expressed in plasma of pancreatic cancer
ABUE, M., YOKOYAMA, M., SHIBUYA, R., TAMAI, K., YAMAGUCHI, K., SATO, I., TANAKA, N., HAMADA, S., SHIMOSEGAWA, T., SUGAMURA, K., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2014.2743 · Cited by 191
Song, T., Xu, A., Zhang, Z., Gao, F., Zhao, L., Chen, X., Gao, J., & Kong, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28128 · Cited by 186
Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
Pujol, P., Barberis, M., Beer, P., Friedman, E., Piulats, J. M., Capoluongo, E. D., Garcia Foncillas, J., Ray-Coquard, I., Penault-Llorca, F., Foulkes, W. D., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2020.12.023 · Cited by 184
Lipidomic profiling of human serum enables detection of pancreatic cancer
Wolrab, D., Jirásko, R., Cífková, E., Höring, M., Mei, D., Chocholoušková, M., Peterka, O., Idkowiak, J., Hrnčiarová, T., Kuchař, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27765-9 · Cited by 182
Barrow, H., Guo, X., Wandall, H. H., Pedersen, J. W., Fu, B., Zhao, Q., Chen, C., Rhodes, J. M., & Yu, L.-G. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1462 · Cited by 181
Serum CEA levels in 49 different types of cancer and noncancer diseases
Hao, C., Zhang, G., & Zhang, L. (2019) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2018.12.011 · Cited by 181
Luga, V., & Wrana, J. L. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1791 · Cited by 179
Casak, S. J., Marcus, L., Fashoyin-Aje, L., Mushti, S. L., Cheng, J., Shen, Y.-L., Pierce, W. F., Her, L., Goldberg, K. B., Theoret, M. R., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0557 · Cited by 179
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
Tikkinen, K. A. O., Dahm, P., Lytvyn, L., Heen, A. F., Vernooij, R. W. M., Siemieniuk, R. A. C., Wheeler, R., Vaughan, B., Fobuzi, A. C., Blanker, M. H., et al. (2018) · BMJ · doi:10.1136/bmj.k3581 · Cited by 176
Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond
Mankoff, D. A., Eary, J. F., Link, J. M., Muzi, M., Rajendran, J. G., Spence, A. M., & Krohn, K. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0074 · Cited by 175
Fan, H.-Y., Liu, Z., Cahill, N., & Richards, J. S. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0095 · Cited by 174
MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications
Stahlhut, C., & Slack, F. J. (2013) · Genome Medicine · doi:10.1186/gm516 · Cited by 174
Laderach, D. J., Gentilini, L. D., Giribaldi, L., Delgado, V. C., Nugnes, L., Croci, D. O., Al Nakouzi, N., Sacca, P., Casas, G., Mazza, O., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1260 · Cited by 170
CAO, M., SEIKE, M., SOENO, C., MIZUTANI, H., KITAMURA, K., MINEGISHI, Y., NORO, R., YOSHIMURA, A., CAI, L., & GEMMA, A. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1535 · Cited by 169
Nucleotide metabolism, oncogene-induced senescence and cancer
Aird, K. M., & Zhang, R. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.01.017 · Cited by 166
Weichert, W., Denkert, C., Burkhardt, M., Gansukh, T., Bellach, J., Altevogt, P., Dietel, M., & Kristiansen, G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0606 · Cited by 163
Development of transcriptomic biomarker signature in human saliva to detect lung cancer
Zhang, L., Xiao, H., Zhou, H., Santiago, S., Lee, J. M., Garon, E. B., Yang, J., Brinkmann, O., Yan, X., Akin, D., et al. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1027-0 · Cited by 162
TCA Cycle Defects and Cancer: When Metabolism Tunes Redox State
Cardaci, S., & Ciriolo, M. R. (2012) · International Journal of Cell Biology · doi:10.1155/2012/161837 · Cited by 161
Na, F., Wang, J., Li, C., Deng, L., Xue, J., & Lu, Y. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000185 · Cited by 160
Vallabhajosula, S., Killeen, R. P., & Osborne, J. R. (2010) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2010.02.004 · Cited by 158
Detection of Exosomal miRNAs in the Plasma of Melanoma Patients
Pfeffer, S. R., Grossmann, K. F., Cassidy, P. B., Yang, C. H., Fan, M., Kopelovich, L., Leachman, S. A., & Pfeffer, L. M. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4121957 · Cited by 158
Meng, E., Mitra, A., Tripathi, K. K., Finan, M. A., Scalici, J. M., McClellan, S., da Silva, L. M., Reed, E., Shevde, L. A., Palle, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107142 · Cited by 157
RAS signaling pathways, mutations and their role in colorectal cancer
Zenonos, K. (2013) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v5.i5.97 · Cited by 156
Carlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Erban, J. K., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2011) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2011.0016 · Cited by 153
Ben‐Yehuda, D., Polliack, A., Okon, E., Sherman, Y., Fields, S. I., Lebenshart, P., Lotan, H., & Libson, E. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.9.2431 · Cited by 151
Liao, J., Liu, R., SHI, Y.-J., Yin, L., & Pu, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3453 · Cited by 150
Infection of human papillomaviruses in cancers of different human organ sites.
Shukla, S., Bharti, A. C., Mahata, S., Hussain, S., Kumar, R., Hedau, S. T., & Das, B. C. (2009) · PubMed · Cited by 146
Kimura, H., Yamamoto, H., Harada, T., Fumoto, K., Osugi, Y., Sada, R., Maehara, N., Hikita, H., Mori, S., Eguchi, H., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2124 · Cited by 145
Laere, B. D., van Dam, P., Whitington, T., Mayrhofer, M., Diaz, E. H., den Eynden, G. V., Vandebroek, J., Del‐Favero, J., Laere, S. V., Dirix, L. Y., et al. (2017) · European Urology · doi:10.1016/j.eururo.2017.01.011 · Cited by 143
Fluorescent imaging of cancerous tissues for targeted surgery
Bu, L., Shen, B., & Cheng, Z. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.008 · Cited by 142
CA 15–3: A Prognostic Marker in Breast Cancer
Duffy, M. J., Shering, S. G., Sherry, F., McDermott, E. W. M., & O’Higgins, N. J. (2000) · The International Journal of Biological Markers · doi:10.1177/172460080001500410 · Cited by 142
Mechanisms of HTLV-1 persistence and transformation
Boxus, M., & Willems, L. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605345 · Cited by 141
Role of image-guided core-needle biopsy in the management of patients with lymphoma.
Pappa, V. I., Hussain, H. K., Reznek, R. H., Whelan, J., Norton, A. J., Wilson, A., Love, S., Lister, T. A., & Rohatiner, A. Z. S. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.9.2427 · Cited by 140
Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms
Moss, S. F., Krivosheyev, V., Souza, A., Chin, K., Gaetz, H. P., Chaudhary, N., Worman, H. J., & Holt, P. R. (1999) · Gut · doi:10.1136/gut.45.5.723 · Cited by 140
Burstein, H. J., Mangu, P. B., Somerfield, M. R., Schrag, D., Samson, D. J., Holt, L., Zelman, D., & Ajani, J. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.0354 · Cited by 139
A distinct molecular profile associated with mucinous epithelial ovarian cancer
Heinzelmann-Schwarz, V. A., Gardiner‐Garden, M., Henshall, S. M., Scurry, J., Scolyer, R. A., Smith, A. N., Bali, A., Bergh, P. M. V., Baron-Hay, S. E., Scott, C. D., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603003 · Cited by 137
Plasma Epstein-Barr Virus (EBV) DNA Is a Biomarker for EBV-Positive Hodgkin's Lymphoma
Gandhi, M. K., Lambley, E., Burrows, J. M., Dua, U., Elliott, S. L., Shaw, P. J., Prince, H. M., Wolf, M. M., Clarke, K., Underhill, C. R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2008 · Cited by 137
Kirk, G. D. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl060 · Cited by 136
Galectins as Molecular Targets for Therapeutic Intervention
Dings, R. P. M., Miller, M. C., Griffin, R. J., & Mayo, K. H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030905 · Cited by 136
Cited by
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
Al-Thani, A. N., Jan, A. G., Abbas, M., Geetha, M., & Sadasivuni, K. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122899 · Cited by 323
The impact of AI on modern oncology from early detection to personalized cancer treatment
Li, J., Zhang, L., Yu, Z., Bao, Z., Li, D., & Wang, L. (2026) · npj Precision Oncology · doi:10.1038/s41698-026-01276-6 · Cited by 24
Metadata
- Authors
- Das, S., Dey, M. K., Devireddy, R., & Gartia, M. R.
- Venue
- Sensors
- Publisher
- MDPI AG
- Published
- 2023-12-20
- Volume
- 24
- Issue
- 1
- Pages
- 37
- ISSN
- 1424-8220 (ISSN-L)
- OpenAlex
- W4389992195
- Cited by
- 383
- References
- 348
- FWCI
- 37.18
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.